Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants

NCT04991571 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Zibotentan (Treatment A)
DRUG: Dapagliflozin (Treatment A)
DRUG: Zibotentan/Dapagliflozin - Formulation 1 (Treatment B)
DRUG: Zibotentan/Dapagliflozin - Formulation 2 (Treatment C)

Sponsor

AstraZeneca